1. Home
  2. NTRA vs TS Comparison

NTRA vs TS Comparison

Compare NTRA & TS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • TS
  • Stock Information
  • Founded
  • NTRA 2003
  • TS 2001
  • Country
  • NTRA United States
  • TS Luxembourg
  • Employees
  • NTRA N/A
  • TS N/A
  • Industry
  • NTRA Medical Specialities
  • TS Steel/Iron Ore
  • Sector
  • NTRA Health Care
  • TS Industrials
  • Exchange
  • NTRA Nasdaq
  • TS Nasdaq
  • Market Cap
  • NTRA 20.9B
  • TS 22.7B
  • IPO Year
  • NTRA 2015
  • TS N/A
  • Fundamental
  • Price
  • NTRA $151.95
  • TS $34.06
  • Analyst Decision
  • NTRA Strong Buy
  • TS Strong Buy
  • Analyst Count
  • NTRA 17
  • TS 5
  • Target Price
  • NTRA $178.41
  • TS $45.20
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • TS 1.7M
  • Earning Date
  • NTRA 05-08-2025
  • TS 04-30-2025
  • Dividend Yield
  • NTRA N/A
  • TS 3.23%
  • EPS Growth
  • NTRA N/A
  • TS N/A
  • EPS
  • NTRA N/A
  • TS 1.63
  • Revenue
  • NTRA $1,831,000,000.00
  • TS $12,004,602,000.00
  • Revenue This Year
  • NTRA $15.45
  • TS N/A
  • Revenue Next Year
  • NTRA $18.43
  • TS $1.72
  • P/E Ratio
  • NTRA N/A
  • TS $10.01
  • Revenue Growth
  • NTRA 51.50
  • TS N/A
  • 52 Week Low
  • NTRA $92.14
  • TS $27.24
  • 52 Week High
  • NTRA $183.00
  • TS $40.87
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 49.96
  • TS 50.23
  • Support Level
  • NTRA $153.40
  • TS $32.97
  • Resistance Level
  • NTRA $159.15
  • TS $33.93
  • Average True Range (ATR)
  • NTRA 6.36
  • TS 0.70
  • MACD
  • NTRA 0.65
  • TS 0.26
  • Stochastic Oscillator
  • NTRA 39.44
  • TS 94.65

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TS Tenaris S.A.

Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the U.S., Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.

Share on Social Networks: